PortfoliosLab logo

China Resources Pharmaceutical Group Ltd (3320.HK)

Equity · Currency in HKD · Last updated May 27, 2023

Company Info

ISINHK0000311099
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market CapHK$45.42B
EPSHK$0.69
PE Ratio10.95
PEG Ratio4.63
Revenue (TTM)HK$254.11B
Gross Profit (TTM)HK$39.13B
EBITDA (TTM)HK$13.92B
Year RangeHK$4.05 - HK$8.13
Target PriceHK$7.91

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of HK$10,000 in China Resources Pharmaceutical Group Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%80.00%100.00%December2023FebruaryMarchAprilMay
-7.46%
94.35%
3320.HK (China Resources Pharmaceutical Group Ltd)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 3320.HK

Return

China Resources Pharmaceutical Group Ltd had a return of 14.40% year-to-date (YTD) and 76.10% in the last 12 months. Over the past 10 years, China Resources Pharmaceutical Group Ltd had an annualized return of -1.20%, while the S&P 500 had an annualized return of 10.91%, indicating that China Resources Pharmaceutical Group Ltd did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-7.07%-0.59%
Year-To-Date14.40%7.47%
6 months16.24%4.51%
1 year76.10%-4.20%
5 years (annualized)-6.37%8.50%
10 years (annualized)-1.20%10.91%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-6.65%9.32%-3.57%25.08%
2022-1.67%20.75%-1.25%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for China Resources Pharmaceutical Group Ltd (3320.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
3320.HK
China Resources Pharmaceutical Group Ltd
1.48
^GSPC
S&P 500
0.27

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current China Resources Pharmaceutical Group Ltd Sharpe ratio is 1.48. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


-1.000.001.002.003.00December2023FebruaryMarchAprilMay
1.48
0.07
3320.HK (China Resources Pharmaceutical Group Ltd)
Benchmark (^GSPC)

Dividend History

China Resources Pharmaceutical Group Ltd granted a 2.07% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.15 per share.


PeriodTTM202220212020201920182017
DividendHK$0.15HK$0.15HK$0.12HK$0.22HK$0.13HK$0.11HK$0.09

Dividend yield

2.07%2.37%3.69%5.86%2.01%1.22%1.02%

Monthly Dividends

The table displays the monthly dividend distributions for China Resources Pharmaceutical Group Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2023HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.15HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.12HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.22HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.13HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2018HK$0.00HK$0.00HK$0.00HK$0.00HK$0.11HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2017HK$0.09HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-50.00%-40.00%-30.00%-20.00%-10.00%December2023FebruaryMarchAprilMay
-36.05%
-12.22%
3320.HK (China Resources Pharmaceutical Group Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the China Resources Pharmaceutical Group Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the China Resources Pharmaceutical Group Ltd is 72.81%, recorded on Dec 20, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-72.81%Sep 4, 2018813Dec 20, 2021
-19.23%Apr 9, 201860Jul 5, 201839Aug 29, 201899
-10.08%Jul 4, 201729Aug 11, 201766Nov 16, 201795
-8.85%Jan 22, 201815Feb 9, 20185Feb 20, 201820
-8.72%Nov 17, 201714Dec 6, 201719Jan 5, 201833

Volatility Chart

The current China Resources Pharmaceutical Group Ltd volatility is 13.91%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%December2023FebruaryMarchAprilMay
13.91%
4.15%
3320.HK (China Resources Pharmaceutical Group Ltd)
Benchmark (^GSPC)